Volume 39 Issue 7
Jul.  2023
Turn off MathJax
Article Contents
Article Navigation >  Journal of Nanjing University of traditional Chinese Medicine  > 2023  >  39(7): 677-682
LI Ying, JIAO Ya-yun, MI Zi-shuo, PEI Li-xia, YU Xiao-yao, CHEN Hao. Clinical Study on Ginger Moxibustion Combined with Adalimumab to Improve Anxiety and Life Quality in Patients with Crohn's Disease at Mild and Moderate Active Stages[J]. Journal of Nanjing University of traditional Chinese Medicine, 2023, 39(7): 677-682. doi: 10.14148/j.issn.1672-0482.2023.0677
Citation: LI Ying, JIAO Ya-yun, MI Zi-shuo, PEI Li-xia, YU Xiao-yao, CHEN Hao. Clinical Study on Ginger Moxibustion Combined with Adalimumab to Improve Anxiety and Life Quality in Patients with Crohn's Disease at Mild and Moderate Active Stages[J]. Journal of Nanjing University of traditional Chinese Medicine, 2023, 39(7): 677-682. doi: 10.14148/j.issn.1672-0482.2023.0677
shu

Clinical Study on Ginger Moxibustion Combined with Adalimumab to Improve Anxiety and Life Quality in Patients with Crohn's Disease at Mild and Moderate Active Stages

doi: 10.14148/j.issn.1672-0482.2023.0677
  • 1.

    Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing 210029, China

  • 2.

    School of Acupuncture-Moxibustion and Massage, School of Health and Rehabilitation, Nanjing University of Chinese Medicine, Nanjing 210023, China

  • Received Date: 2023-03-21
    Available Online: 2023-07-15
    Abstract
  •   OBJECTIVE  To observe the effect of ginger moxibustion combined with Adalimumab on the mood and life quality of patients with anxiety and Crohn's disease at mild and moderate active stages.  METHODS  60 patients with anxiety and Crohn's disease at mild and moderate active stages who met the inclusion criteria were selected and randomly divided into the treatment group and control group with 30 cases each.The control group was given a standardized treatment of Adalimumab, and the treatment group was treated with ginger moxibustion on the basis of the control group.The course of treatment was 12 weeks.Observe the changes in TCM syndrome score and clinical efficacy, anxiety relief response rate, Crohn's disease activity index (CDAI) score, Inflammatory bowel disease quality of life (IBDQ) score, and safety indicators of the two groups of patients before and after treatment.  RESULTS  After treatment, the TCM syndrome scores of both groups were significantly reduced (P < 0.05, P < 0.01), and the treatment group was superior to the control group (P < 0.05, P < 0.01);the clinical efficacy and anxiety relief response rate of the treatment group were better than those of the control group (P < 0.05);the IBDQ scores of both groups were significantly increased (P < 0.05, P < 0.01), and the treatment group was better than the control group (P < 0.05);the CDAI scores of both groups significantly decreased (P < 0.05, P < 0.01), and the treatment group was better than the control group (P < 0.05, P < 0.01).  CONCLUSION  Ginger moxibustion combined with Adalimumab can improve the anxiety and life quality of patients with Crohn's disease at mild and moderate active stages.

     

    • FullText(HTML)
  • loading
    • References(21)
  • [1]
    李冠炜, 任建安. 重视我国克罗恩病流行病学的研究[J]. 肠外与肠内营养, 2017, 24(3): 135-137. https://www.cnki.com.cn/Article/CJFDTOTAL-CWCN201703004.htm

    LI GW, REN JA. Attach importance to the epidemiological study of Crohn's disease in China[J]. Parenter Enter Nutr, 2017, 24(3): 135-137. https://www.cnki.com.cn/Article/CJFDTOTAL-CWCN201703004.htm
    [2]
    MACALUSO FS, PAPI C, ORLANDO A, et al. Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology[J]. Dig Liver Dis, 2023, 55(4): 442-453. doi: 10.1016/j.dld.2023.01.155
    [3]
    容加梅, 罗娟, 黄奇, 等. 炎症性肠病治疗中生物制剂的个体化选择[J]. 世界华人消化杂志, 2021, 29(15): 893-900. https://www.cnki.com.cn/Article/CJFDTOTAL-XXHB202115011.htm

    RONG JM, LUO J, HUANG Q, et al. Individualized selection of biological agents in treatment of inflammatory bowel disease[J]. World Chin J Dig, 2021, 29(15): 893-900. https://www.cnki.com.cn/Article/CJFDTOTAL-XXHB202115011.htm
    [4]
    沈洪, 朱磊, 张露. 生物制剂背景下克罗恩病中西医结合治疗策略探讨[J]. 南京中医药大学学报, 2022, 38(8): 739-742. doi: 10.14148/j.issn.1672-0482.2022.0739

    SHEN H, ZHU L, ZHANG L. Exploration of treatment strategies with integrated traditional Chinese and western medicine for Crohn's disease under the background of biological agents[J]. J Nanjing Univ Tradit Chin Med, 2022, 38(8): 739-742. doi: 10.14148/j.issn.1672-0482.2022.0739
    [5]
    曾理, 刘迈兰, 谭舒怀, 等. 灸法对新型冠状病毒肺炎密切接触者心理障碍的影响: 随机对照研究[J]. 中国针灸, 2021, 41(10): 1109-1112. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZE202110011.htm

    ZENG L, LIU ML, TAN SH, et al. Moxibustion on mental disorder in close contacts of coronavirus disease 2019: A randomized controlled trial[J]. Chin Acupunct Moxibustion, 2021, 41(10): 1109-1112. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZE202110011.htm
    [6]
    ZHANG D, YUAN XX, WANG BY, et al. Observation on effects of moxibustion at abdominal acupoints for slow transit constipation due to Yang deficiency of the spleen and kidney[J]. J Acupunct Tuina Sci, 2017, 15(6): 426-433. doi: 10.1007/s11726-017-1040-9
    [7]
    吴开春, 梁洁, 冉志华, 等. 炎症性肠病诊断与治疗的共识意见(2018年·北京)[J]. 中国实用内科杂志, 2018, 38(9): 796-813. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201809007.htm

    WU KC, LIANG J, RAN ZH. et al. Chinese consensus on diagnosis and treatment of inflammatory bowel disease(Beijing, 2018)[J]. Chin J Pract Intern Med, 2018, 38(9): 796-813. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201809007.htm
    [8]
    张明园. 精神科评定量表手册[M]. 2版. 长沙: 湖南科学技术出版社, 1998: 122.

    ZHANG MY. Handbook of Rating Scales in Psychiatry[M]. 2nd ed. Changsha: Hunan science & technology press, 1998: 122.
    [9]
    中华中医药学会脾胃病分会. 中医消化病诊疗指南[M]. 北京: 中国中医药出版社, 2006: 87.

    Spleen and Stomach Disease Branch of China Association of Chinese Medicine. Guidelines for Diagnosis and Treatment of Digestive Diseases in Traditional Chinese Medicine[M]. Beijing: China press of traditional Chinese medicine, 2006: 87.
    [10]
    中药新药临床研究指导原则: 试行[M]. 北京: 中国医药科技出版社, 2002: 343-345.

    Guiding Principles for Clinical Research of New Chinese Medicine: Trial Implementation[M]. Beijing: China medical science press, 2002: 343-345.
    [11]
    中华医学会消化病学分会炎症性肠病学组. 抗肿瘤坏死因子α单克隆抗体治疗炎症性肠病专家共识(2017)[J]. 协和医学杂志, 2017, 8(4/5): 239-243. https://www.cnki.com.cn/Article/CJFDTOTAL-XHYX2017Z2011.htm

    Inflammatory Bowel Disease Group, Gastroenterology Branch of Chinese Medical Association. Expert consensus of anti-TNF-α monoclonal antibody in the treatment of inflammatory bowel disease (2017)[J]. Med J Peking Union Med Coll Hosp, 2017, 8(4/5): 239-243. https://www.cnki.com.cn/Article/CJFDTOTAL-XHYX2017Z2011.htm
    [12]
    周青杨, 杨红, 钱家鸣. 克罗恩病的疾病活动度评分及相关评估指标研究[J]. 胃肠病学和肝病学杂志, 2020, 29(9): 961-964. https://www.cnki.com.cn/Article/CJFDTOTAL-WCBX202009001.htm

    ZHOU QY, YANG H, QIAN JM. Research on disease activity assessment index and predictor of Crohn's disease[J]. Chin J Gastroenterol Hepatol, 2020, 29(9): 961-964. https://www.cnki.com.cn/Article/CJFDTOTAL-WCBX202009001.htm
    [13]
    穆尔扎·别克, 杨雪松, 张拓红. 简体中文版炎性肠病量表的信度和效度评价[J]. 北京大学学报(医学版), 2011, 43(3): 477-480. https://www.cnki.com.cn/Article/CJFDTOTAL-BYDB201103037.htm

    MURZA B, YANG YS, ZHANG TH. Reliability and validity evaluation of simplified Chinese version of inflammatory bowel disease scale[J]. J Peking Univ Heath Sci, 2011, 43(3): 477-480. https://www.cnki.com.cn/Article/CJFDTOTAL-BYDB201103037.htm
    [14]
    唐毛毛, 汪春莲, 张洁, 等. 克罗恩病患者93例使用阿达木单抗治疗的疗效和安全性分析[J]. 中华消化杂志, 2022, 42(6): 406-410.

    TANG MM, WANG CL, ZHANG J, et al. Efficacy and safety of adalimumab in 93 patients with Crohn ' s disease[J]. Chin J Dig, 2022, 42(6): 406-410.
    [15]
    叶子萍, 赵小静, 焦春花, 等. 克罗恩病患者精神心理及迷走神经功能改变与临床特征的相关性分析[J]. 南京医科大学学报(自然科学版), 2022, 42(11): 1553-1559. https://www.cnki.com.cn/Article/CJFDTOTAL-NJYK202211008.htm

    YE ZP, ZHAO XJ, JIAO CH, et al. The correlation between the changes of psychophysiology and vagus nerve function and clinical characteristics in patients with Crohn's disease[J]. J Nanjing Med Univ Nat Sci, 2022, 42(11): 1553-1559. https://www.cnki.com.cn/Article/CJFDTOTAL-NJYK202211008.htm
    [16]
    吴昆. 医方考[M]. 南京: 江苏科学技术出版社, 1985: 111.

    WU K. Investigations of Medical Formulas[M]. Nanjing: Jiangsu science & technology press, 1985: 111.
    [17]
    韩金钱, 张宜佳, 蒋恩社. 艾灸对癌症病人癌因性疲乏干预效果的Meta分析[J]. 循证护理, 2021, 7(6): 719-726. https://www.cnki.com.cn/Article/CJFDTOTAL-XZHL202106003.htm

    HAN JQ, ZHANG YJ, JIANG ES. Intervention effect of moxibustion on cancer-related fatigue in cancer patients: A Meta-analysis[J]. Chin Evid Based Nurs, 2021, 7(6): 719-726. https://www.cnki.com.cn/Article/CJFDTOTAL-XZHL202106003.htm
    [18]
    路玫, 张丽繁, 袁晔, 等. 隔姜灸、悬灸对不同穴位各时段热感度的对比研究[J]. 中国针灸, 2011, 31(3): 232-235. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZE201103017.htm

    LU M, ZHANG LF, YUAN Y, et al. Comparison on heat sensation degree of ginger-partition moxibustion and suspended moxibustion at different acupoints for different time[J]. Chin Acupunct Moxibust, 2011, 31(3): 232-235. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZE201103017.htm
    [19]
    李景荣. 备急千金要方校注[M]. 北京: 人民卫生出版社, 1998: 651.

    LI JR. Corrections and Annotations to Important Formulas Worth A Thousand Gold Pieces[M]. Beijing: People's medical publishing house, 1998: 651.
    [20]
    韩兴军, 郑雅峰, 王璇, 等. 灸神阙、针刺组穴对抑郁型大鼠不同脑区神经递质影响[J]. 辽宁中医药大学学报, 2018, 20(8): 154-158. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB201808047.htm

    HAN XJ, ZHENG YF, WANG X, et al. Effect of moxibustion on Shenque and acupuncture at different acupoints on neurotransmitters in different brain regions of depression rats[J]. J Liaoning Univ Tradit Chin Med, 2018, 20(8): 154-158. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB201808047.htm
    [21]
    杨淑荃, 范德辉, 袁智先, 等. 基于"脑肠相通"的腹针埋线疗法治疗轻中度阿尔茨海默病及对血清APP、Aβ1-42的影响[J]. 中国针灸, 2021, 41(11): 1231-1235. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZE202111014.htm

    YANG SQ, FAN DH, YUAN ZX, et al. Abdominal acupoint thread embedding therapy based on "brain-intestinal connection" for mild-to-moderate Alzheimer's disease and its effects on serum levels of APP and Aβ1-42[J]. Chin Acupunct Moxibust, 2021, 41(11): 1231-1235. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZE202111014.htm
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(7)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (212) PDF downloads(13) Cited by()
    Proportional views
    Related

    Copyright © Journal of Nanjing University of traditional Chinese Medicine

    Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023

    Tel：025-85811935Email：xb@njucm.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return